Advancing Lupus Care: The Changing Landscape of Treatment
The progression toward more targeted, disease-modifying options for the historically difficult rheumatic disease made more headway in 2023.
Source: hcplive.com
Active Systemic Lupus News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Active Systemic Lupus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Active Systemic Lupus Today - Breaking & Trending Today
Promising Data Shows Lupus Research Alliance Peer Education Program Increases Willingness to Join Clinical Trials Among Diverse Patient Population
/PRNewswire/ -- The Lupus Research Alliance and its affiliate Lupus Therapeutics will present data at ACR Convergence 2022 with results showing the...
Source: prnewswire.com
Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC: Saphnelo approved in EU for SLE
Investegate announcements from AstraZeneca PLC, Saphnelo approved in EU for SLE
Source: investegate.co.uk
Saphnelo approved in the EU for the treatment of moderate to severe systemic lupus erythematosus
AstraZeneca’s Saphnelo (anifrolumab) has been approved in the European Union as an add-on therapy for the treatment of adult patients with moderate to severe, active autoantibody-positive systemic lupus erythematosus (SLE), despite receiving standard therapy. Saphnelo is the first biologic for SLE approved in ...
Source: pharmiweb.com
Saphnelo approved in the EU for the treatment of moderate to severe systemic lupus erythematosus
Saphnelo approved in the EU for the treatment of moderate to severe systemic lupus erythematosusSaphnelo is a first-in-class type I interferon receptor antibody and the only new medicine in over a decade for patients with systemic lupus erythematosusAstraZeneca’s Saphnelo (anifrolumab) has been approved in the...
Source: pharmiweb.com